Mark Shackleton
Monash University
H-index: 40
Oceania-Australia
Top articles of Mark Shackleton
Malignancy risk and mortality after lung transplantation: a single institution experience over 31 years
JHLT Open
2024/4/4
Symptomatic brain metastases in melanoma
2024/4
Mark Shackleton
H-Index: 29
Malaka Ameratunga
H-Index: 11
Globe salvage and vision preservation by neoadjuvant darovasertib and crizotinib in uveal melanoma
Ophthalmology Retina
2024/4/1
Malaka Ameratunga
H-Index: 11
Mark Shackleton
H-Index: 29
Computational repurposing of oncology drugs through off‐target drug binding interactions from pharmacological databases
Clinical and Translational Medicine
2024/4
Molecular and functional characterization of melanocyte subpopulations in human epidermis based on single-cell RNA sequencing
Cancer Research
2024/3/22
Statin use in resected, high-risk cutaneous melanoma: A multi-centre retrospective cohort study
EJC Skin Cancer
2024/1/1
Publisher Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
Nature genetics
2023/5
1233 Exploring the role of melanocyte subpopulations in vitiligo
Journal of Investigative Dermatology
2023/5/1
UHRF1/UBE2L6/UBR4-mediated ubiquitination regulates EZH2 abundance and thereby melanocytic differentiation phenotypes in melanoma
Oncogene
2023/4/21
A capability framework to inform the fundamental requirements for clinical trial unit development, growth and long term success in outer metropolitan and rural areas
Contemporary Clinical Trials Communications
2023/4/1
Mark Shackleton
H-Index: 29
Author Correction: Pan-cancer analysis of whole genomes
Nature
2023/2/16
Immune-related adverse events are associated with therapeutic efficacy of immunotherapy in patients with melanoma brain metastases
2019/3/1
Design, optimisation and standardisation of a high‐dimensional spectral flow cytometry workflow assessing T‐cell immunophenotype in patients with melanoma
Clinical & Translational Immunology
2023
Robin Smith
H-Index: 20
Mark Shackleton
H-Index: 29
The role of surveillance imaging for resected high‐risk melanoma
Asia‐Pacific Journal of Clinical Oncology
2023/8
Statins and Progression of Coronary Atherosclerosis in Melanoma Patients Treated with Immune Checkpoint Inhibitors (SOCRATES): Rationale and Design
Heart, Lung and Circulation
2023/7/1
Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
Nature genetics
2023/6
Immune-related adverse events secondary to immunotherapy in oncology: A guide for general practice
Australian Journal of General Practice
2023/6/1
Mark Shackleton
H-Index: 29
NADOM trial: Neoadjuvant/adjuvant trial of darovasertib in ocular melanoma (OM).
2023/6/1
CHARLI: A phase Ib/II trial of ipilimumab-nivolumab-denosumab or nivolumab-denosumab in patients with unresectable stage III and IV melanoma.
Journal of Clinical Oncology
2023/6/1
A Phase 1 Dose-Escalation Study to Investigate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamic Activity of CLN-619 (Anti-MICA/MICB Antibody) Alone and in …
2023/6/1
